LANREOTIDE vs LAROTRECTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LANREOTIDE vs LAROTRECTINIB: Safety Overview
| Metric | LANREOTIDE | LAROTRECTINIB |
|---|---|---|
| Total FAERS Reports | 9,007 | 798 |
| Deaths Reported | 1,434 | 149 |
| Death Rate | 15.9% | 18.7% |
| Hospitalizations | 2,178 | 151 |
| Average Patient Age | 60.2 yrs | 48.9 yrs |
| % Female Patients | 53.8% | 51.5% |
| FDA Approval Date | Aug 30, 2007 | Nov 26, 2018 |
| Manufacturer | Cipla USA Inc. | Bayer HealthCare Pharmaceuticals Inc. |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | Prescription | Prescription |